News Center

位置：

Honors Announcement

Group News

Media Reports

Pragmatic Action Seizes the Early Spring—Now Is the Time to Forge Ahead: Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group Holds Its 2026 Policy and Target Launch Conference

Category:

Group News

发布时间：2026-02-25

【概要描述】 On February 10, Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group held its 2026 Policy and Target Launch Conference. Mid- and senior-level managers from the company gathered to discuss major development strategies and systematically map out a new blueprint for high-quality development during the 2026–2030 period and the 15th Five-Year Plan period. The conference was chaired by Zhang Zanyuan, General Manager of Guangxiang Pharmaceutical.

Pragmatic Action Seizes the Early Spring—Now Is the Time to Forge Ahead: Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group Holds Its 2026 Policy and Target Launch Conference

On February 10, Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group held its 2026 Policy and Objective Launch Conference. Mid- and senior-level managers from the company gathered to discuss major development strategies and systematically map out a new blueprint for high-quality development during the 2026–2030 period and the 15th Five-Year Plan period. The conference was chaired by Zhang Zanyuan, General Manager of Guangxiang Pharmaceutical.

At the meeting, Zhang Zanyuan began by providing an overview of the company’s work in formulating the 2026 policy objectives. He emphasized that these objectives are closely aligned with the Group’s strategic decisions and the “15th Five-Year” strategic plan, while also taking into account the actual development needs of Guangxiang Pharmaceutical. Following multiple rounds of deliberation and thorough validation, a comprehensive annual target system has been established, covering key dimensions such as quality, safety, innovation, and performance, and characterized by both ambition and forward-looking vision.

During the policy and objective announcement session, 20 heads from various workshops and departments at Guangxiang Pharmaceutical took to the stage one by one to report on their progress toward the year’s targets, making clear commitments, outlining action plans, and setting specific measures. Company leaders listened attentively to each presentation and provided focused feedback and guidance, offering targeted recommendations for enhancement and improvement.

Zhu Shujie, Chairman of Guangxiang Pharmaceutical, delivered a concluding address. He noted that in 2025, all employees of Guangxiang rose to the challenge posed by the profound adjustments underway in both the domestic and international pharmaceutical markets, diligently implemented the Group’s work plan, and, driven by the courage to “press forward all the more in the face of adversity” and the sense of responsibility to “remain constantly vigilant,” worked tirelessly and overcame numerous difficulties, achieving results that were truly hard-won. He extended his most sincere gratitude and highest respect to every employee who has devoted their sweat and efforts to the development of Guangxiang Pharmaceutical.

To ensure the comprehensive and effective execution of 2026 business operations, Zhu Shujie emphasized that 2026 marks the inaugural year of the company’s 15th Five-Year Plan—a pivotal year characterized by both opportunities and challenges, and one that is critical for breaking through bottlenecks and achieving leapfrog development. He urged management at all levels and all employees to fully, accurately, and comprehensively implement the new development philosophy, foster a new development paradigm, further align their thinking and actions with the strategic directives of the Group’s Board of Directors, and steadfastly anchor themselves to the goal of high-quality development. Specifically, he called for: first, taking strengthened management as the overarching priority, rigorously assigning responsibilities and boosting execution effectiveness to ensure that all Group-wide management requirements are effectively implemented and take root at Guangxiang Pharmaceutical; second, regarding quality and safety as the lifeline, building a solid foundation for stable and sustainable growth, and resolutely safeguarding the areas of responsibility entrusted by the Group; third, using cost reduction and efficiency enhancement as the breakthrough point to strengthen competitive edge and contribute Guangxiang Pharmaceutical’s strength to the overall improvement of Group performance; fourth, positioning innovation as the core engine to unleash new momentum for high-quality development and better integrate into the Group’s science-and-technology innovation system; and fifth, leveraging project applications as a key support to expand new avenues for development and demonstrate greater impact within the Group’s strategic framework.

“Pragmatic action ushers in spring early, and now is the perfect time to forge ahead.” Attendees unanimously pledged to anchor themselves to the new goals, summoning the vigorous drive of “leaving footprints on every stone and leaving marks on every patch of iron” and the tenacious perseverance of “dripping water wears through stone, requiring sustained effort over the long term,” to spare no effort in achieving all policy objectives and targets. They committed to ensuring the comprehensive implementation and tangible results of key tasks for 2026, elevating Guangxiang Pharmaceutical’s development to a new level, delivering outstanding performance that satisfies the Group, and making a solid contribution to setting a strong start and laying a robust foundation for the 15th Five-Year Plan.

Keywords:

China Pharmaceutical Packaging Association Sends a Letter of Gratitude to Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Devices

Leaders of the Xinghua City Federation of Trade Unions Visit and Extend Condolences to Experts and Talents at Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Devices Division and Present “Outstanding Employee Patent” Certificates

China Pharmaceutical Packaging Association Sends a Letter of Gratitude to Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Devices